Bright Minds Biosciences (DRUG) Gross Profit: 2020-2021
Historic Gross Profit for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to -$124,390.
- Bright Minds Biosciences' Gross Profit was N/A to -$124,390 in Q3 2021 from the same period last year, while for Sep 2021 it was -$316,831, marking a year-over-year change of. This contributed to the annual value of -$312,240 for FY2021, which is 12.63% up from last year.
- Per Bright Minds Biosciences' latest filing, its Gross Profit stood at -$124,390 for Q3 2021, which was up 20.35% from -$156,176 recorded in Q2 2021.
- In the past 5 years, Bright Minds Biosciences' Gross Profit registered a high of -$4,434 during Q4 2020, and its lowest value of -$156,176 during Q2 2021.
- Over the past 2 years, Bright Minds Biosciences' median Gross Profit value was -$78,110 (recorded in 2021), while the average stood at -$79,208.